SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
Sionna Therapeutics, Inc.
@SION_InsiderForm 4 Filing: ORBIMED ADVISORS LLC Sells $3.9M of $SION
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Sionna Therapeutics, Inc.
Ticker: $SION
Transaction Value
$3.9M
Price/Share: $44.86
transaction date
2026-07-07
Shares: 85,918
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ORBIMED ADVISORS LLC, holds the title of Director at Sionna Therapeutics, Inc..
On 2026-07-07, the insider transacted 85,918 shares.The shares were transacted at a weighted average price of $44.86 per share, resulting in a total market-relevant value of $3.9M.
Executive Summary Summary
ORBIMED ADVISORS LLC (Director) sold $3.9M of $SION
Post-Transaction Position: 2,469,959 shares
SEC Accession No: 0000947871-26-000694 (CIK: 1055951)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.